MNA
DXCM icon

Manning & Napier Advisors’s DexCom DXCM Stock Holding History

Manning & Napier Advisors’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-4,791,600
Closed -$26.9M – 337
2013
Q2 		$26.9M Buy
+4,791,600
New +$23M 0.14% 85

Other funds holding DXCM

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
TCP
TAMRO Capital Partners Alexandria, Virginia $369M AUM 1.2% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Manning & Napier Advisors's DXCM Position: Q3 2013 in Review

Manning & Napier Advisors sold out of DexCom (DXCM) in Q3 2013, closing a stake of 4,791,600 shares — an estimated $26.9M sold.

Manning & Napier Advisors first reported a position in DXCM in Q2 2013 and held it in 1 quarter. The position peaked at $26.9M in Q2 2013. 175 funds tracked by Wall St. Rank hold DXCM as of Q3 2013.

  • Manning & Napier Advisors reported no remaining DexCom position as of Q3 2013 after selling out during the quarter.
  • Manning & Napier Advisors sold 4,791,600 DexCom shares in Q3 2013, an estimated $26.9M.
  • Manning & Napier Advisors first reported a position in DexCom in Q2 2013 and held it in 1 quarter.
  • Manning & Napier Advisors's DexCom position peaked at $26.9M in Q2 2013.
  • 175 funds tracked by Wall St. Rank held DexCom as of Q3 2013.

Based on Manning & Napier Advisors's 13F filing for Q3 2013, filed 18 Oct 2013.